Biotech ETFs Soar On Gilead-Kite Deal
August 29, 2017 at 15:56 PM EDT
Through ETF ways, investors get to play the overall evolvement of the biotech space and certain downbeat VGM scores of GILD and KITE would not come in the way of investors’ optimism.
